WaveFront Dynamics, an Albuquerque-based ophthalmology tech startup, closes a $3 million funding round to advance the commercialization of devices for measuring eye aberrations.

Target Overview

WaveFront Dynamics, a spinoff of Albuquerque-based WaveFront Sciences, recently secured $3 million in funding to advance its innovative ophthalmology technology. Founded in May 2019, the company specializes in developing devices that measure aberrations in the eye that lead to vision impairments, with aspirations to create custom contact lenses tailored to individual needs. The CEO, Dan Neal, indicated that the manufacturing machine, crucial for this endeavor, is expected to be priced between $32,000 and $35,000, as the company gears up for commercialization.

Currently, WaveFront Dynamics is conducting a clinical trial involving around 20 participants. This initiative is a significant step in its plan to launch commercially by early next year. The company aims to establish a production operation, creating additional jobs in quality assurance and manufacturing, with an estimated six new hires anticipated by the end of the first quarter of 2022.

Industry Overview

The ophthalmology industry in the United States, particularly in New Mexico, has shown robust growth and innovation in recent years. The state's focus on technology and health services has nurtured a favorable en